CIRM Funded Clinical Trials

A Phase I Study of Multiple doses of NSC-Based Oncolytic Virotherapy Administered Intracerebrally to Patients with Recurrent High-Grade Gliomas

Disease Area:
CIRM Grant:
CLIN2-13162 (Active)
Award Value:
Trial Sponsor:
Beckman Research Institute of City of Hope
Trial Stage:
Phase 1
Trial Status:
Targeted Enrollment:

CIRM Clinical Trial Resources

Patient Stories of Hope

CIRM Alpha Stem Cell Clinics

Patient Toolbox

Video on Stem Cell Trials

Other Resources

ISSCR Patient Website